Evrofarma SA (ATH: EVROF)
Greece
· Delayed Price · Currency is EUR
1.365
-0.055 (-3.87%)
Nov 19, 2024, 5:10 PM EET
Evrofarma Revenue
Evrofarma had revenue of 21.65M EUR in the half year ending June 30, 2024, with 9.90% growth. This brings the company's revenue in the last twelve months to 46.84M, down -4.88% year-over-year. In the year 2023, Evrofarma had annual revenue of 48.76M with 7.45% growth.
Revenue (ttm)
46.84M
Revenue Growth
-4.88%
P/S Ratio
0.40
Revenue / Employee
282.19K
Employees
156
Market Cap
18.87M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48.76M | 3.38M | 7.45% |
Dec 31, 2022 | 45.38M | 8.68M | 23.66% |
Dec 31, 2021 | 36.70M | 2.79M | 8.23% |
Dec 31, 2020 | 33.91M | 429.00K | 1.28% |
Dec 31, 2019 | 33.48M | 945.00K | 2.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Karelia Tobacco Company Inc. | 294.87M |
Kri-Kri Milk Industry S.A. | 234.23M |
Papoutsanis S.A. | 69.78M |
Loulis Food Ingredients S.A. | 200.46M |
Eurobank Ergasias Services and Holdings S.A. | 2.84B |
National Bank of Greece S.A. | 2.80B |